PDF herunterladen
Horm Metab Res 2006; 38(11): 706-720
DOI: 10.1055/s-2006-955082
Review

© Georg Thieme Verlag KG Stuttgart · New York

Macroangiopathy in Adults and Children with Diabetes: Risk Factors (Part 2)

D. Di Marzio 1 , A. Mohn 1 , M. de Martino 2 , F. Chiarelli 1 , 2
  • 1Department of Pediatrics, University of Chieti, Italy
  • 2Department of Pediatrics, University of Florence, “Anna Meyer” Children's Hospital, Florence, Italy
Weitere Informationen

Publikationsverlauf

Received 30 November 2005

Accepted after second revision 14 August 2006

Publikationsdatum:
28. November 2006 (online)

Auch verfügbar auf
    Lizenzen und Reprints

Abstract

Autoimmune or type 1 diabetes mellitus (T1DM), accounts for 90-95% of all cases of diabetes, while type 2 diabetes mellitus (T2DM), characterized by impaired insulin sensitivity and production, accounts for the other 5-10%. Atherosclerotic process starts during childhood and recognize several mechanisms that are activated in response to noxius stimuli and participate in a complex state which is accepted to be a chronic inflammatory state. T1DM patients, especially those with a non-optimal metabolic control, have a higher risk of developing all macrovascular complications such as myocardial infarction, stroke and silent ischemia. Macrovascular disease is mainly associated with hyperglycemia, dyslipidemia, obesity, hypertension, hypercoagulable state, cigarette smoking, lack of exercise, endothelial dysfunction, hyperhomocysteinemia and vascular wall abnormalities. In this paper we review the importance of traditional and non-traditional risk factors for macrovascular complications in children with T1DM and discuss their role in the pathogenesis of the excess cardiovascular mortality in these patients.

Key words

Type 1 diabetes - cardiovascular disease - hyperglycemia - advanced glycation end-products - lipids - nitric oxide - macroangiopathy

References

  • 1 King H, Aubert RE, Herman WH. Global burden of diabetes, 1995-2025: prevalence, numerical estimates, and projections.  Diabetes Care. 1998;  21 1414-1431
    CrossrefPubMedSuche in Google Scholar
  • 2 Orchard TJ, Stevens LK, Forrest KY-Z, Fuller JH. Cardiovascular disease in insulin dependent diabetes mellitus: similar rates but different risk factors in the US compared with Europe.  Int J Epidemiol. 1998;  27 976983
    PubMedSuche in Google Scholar
  • 3 Berenson GS, Wattigney WA, Tracy RE, Newman WP, Srinivasan SR, Webber LS, Dalferes Jr ER, Strong JP. Atherosclerosis of the aorta and coronary arteries and cardiovascular risk factors in persons aged 6 to 30 years and studied at necropsy (The Bogalusa Heart Study).  Am J Cardiol. 1992;  70 851-858
    CrossrefPubMedSuche in Google Scholar
  • 4 National High Blood Pressure Education Program Working Group report on hypertension in diabetes . Hypertension. 1994;  23 145-158
    PubMed
  • 5 Sowers JR, Epstein M. Diabetes mellitus and associated hypertension, vascular disease, and nephropathy. An update.  Hypertension. 1995;  26 869-879
    PubMedSuche in Google Scholar
  • 6 Rossing P, Hougaard P, Borch-Johnsen K, Parving HH. Predictors of mortality in insulin dependent diabetes: 10-year observational follow up study.  Br Med J. 1996;  313 779-784
    PubMedSuche in Google Scholar
  • 7 Stamler J, Vaccaro O, Neaton JD, Wenworth D. Diabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the Multiple Risk Intervention Trial.  Diabetes Care. 1993;  16 434-444
    CrossrefPubMedSuche in Google Scholar
  • 8 Elliot WJ, Maddy R, Toto R, Bakris G. Hypertension in patients with diabetes. Overcoming barriers to effective control.  Postgrad Med. 2000;  107-138
    PubMedSuche in Google Scholar
  • 9 Merimee TJ. Diabetic retinopathy.  N Engl J Med. 1999;  322 978-982
    PubMedSuche in Google Scholar
  • 10 Maser RE, Steenkiste AR, Dorman JS, Nielsen VK, Bass EB, Manjoo Q, Drash AL, Becker DJ, Kuller LH, Green DA. et al . Epidemiological correlates of diabetic neuropathy. Report form Pittsburgh Epidemiology of Diabetes Complications Study.  Diabetes. 1989;  38 1456-1461
    CrossrefPubMedSuche in Google Scholar
  • 11 Fang ZY, Prins JB, Marwick TH. Diabetic cardiomyopathy: evidence, mechanisms, and therapeutic implications.  Endocr Rev. 2004;  25 543-567
    CrossrefPubMedSuche in Google Scholar
  • 12 van Hoeven KH, Factor SM. A comparison of the pathological spectrum of hypertensive, diabetic, and hypertensive-diabetic hearth disease.  Circulation. 1990;  82 848-855
    PubMedSuche in Google Scholar
  • 13 Frustaci A, Kajstura J, Chimenti C, Jakoniuk I, Leri A, Maseri A, Nadal-Ginard B, Anversa P. Myocardial cell death in human diabetes.  Circ Res. 2000;  87 1123-1132
    PubMedSuche in Google Scholar
  • 14 Barzilay J, Warram JH, Bak M, Laffel LMB, Canessa M, Krolewski AS. Predisposition to hypertension: Risk factor for nephropathy and hypertension in IDDM.  Kidney Int. 1992;  41 723-730
    PubMedSuche in Google Scholar
  • 15 Krolewski AS, Canessa M, Warram JH, Laffel LM, Christliev AR, Knowler WC, Rand LI. Predisposition to hypertension and susceptibility to renal disease in insulin-dependent diabetes mellitus.  N Engl J Med. 1998;  318 140-145
    PubMedSuche in Google Scholar
  • 16 Borch-Johnsen K, Kreiner S. Proteinuria: value as predictor of cardiovascular mortality in insulin dependent diabetes mellitus.  Br Med J (Clin Res Ed). 1987;  294 1651-1654
    PubMedSuche in Google Scholar
  • 17 Casani A, Bangstad HJ, Chiarelli F. Detection and management of diabetic glomerulopathy in children and adolescents with insulin-dependent diabetes mellitus: need for improved knowledge and better care.  J Pediatr Endocrinol Metab. 2000;  13 467-474
    PubMedSuche in Google Scholar
  • 18 Mogensen CE. Microalbuinuria, blood pressure and diabetic renal disease. Origin and development of ideas.  Diabetologia. 1999;  42 263-285
    CrossrefPubMedSuche in Google Scholar
  • 19 Gorman D, Sochett E, Daneman D. The natural history of microalbuminuria in adolescents with type 1 diabetes.  J Pediatr. 1999;  134 333-337
    PubMedSuche in Google Scholar
  • 20 Mogensen CE, Keane WF, Bennet PH, Jerums G, Parving HH, Passa P, Steffes MW, Striker GE, Viberti GC. Prevention of diabetic renal disease with special reference to microalbuminuria.  Lancet. 1995;  346 1080-1084
    CrossrefPubMedSuche in Google Scholar
  • 21 Heart Outcomes Prevention Evaluation (HOPE) Study Investigatos . Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICRO-HOPE study.  Lancet. 2000;  355 253-259
    CrossrefPubMedSuche in Google Scholar
  • 22 Hansson L, Zanchetti A, Carruthers SG, Dahlof B, Elmfeldt D, Julius S, Menard J, Rahn KH, Wedel H, Westerling S. Effects of intensive blood-pressure lowering and low-dose aspirin on patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomized trial: HOT Study Group.  Lancet. 1998;  351 1755-1762
    CrossrefPubMedSuche in Google Scholar
  • 23 Joint National Committee on Prevention, Detection, Evaluation and Treatment of High Blood Pressure: the sixth report of the Joint National Committee on Prevention, Decetion, Evaluation and Treatment of High Blood Pressure (JNC VI) . Arch Int Med. 1997;  157 2413-2446
    PubMed
  • 24 UK Prospective Diabetes Study Group Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38 . BMJ. 1998;  317 703-713
    PubMed
  • 25 National High Blood Pressure Education Program Working Group on Hypertension Control in Children and Adolescents . Update on the task force report on high blood pressure in children and adolescents: a working group report from the National High Blood Pressure Education Program.  Pediatrics 1996. 1987;  98 649-658
    PubMedSuche in Google Scholar
  • 26 ISPAD (International Society for Pediatric and Adolescent Diabetes) Consensus Guidelines for the Management of Children and Adolescents with Diabetes.  2000; 
    Suche in Google Scholar
  • 27 Schultz CJ, Konopelska-Bahu T, Dalton RN, Carroll TA, Stratton I, Gale EA, Neil A, Dunger DB. Microalbuminuria prevalence varies with age, sex, and puberty in children with type 1 diabetes followed from diagnosis in a longitudinal study. Oxford Regional Prospective Study Group.  Diabetes Care. 1999;  22 495-502
    CrossrefPubMedSuche in Google Scholar
  • 28 National high blood pressure education program working group on hypertension control in children and adolescents . Update on the 1987 Task Force Report on high blood pressure in children and adolescents.  Pediatrics. 1996;  98 649-658
    PubMedSuche in Google Scholar
  • 29 Hansen KW, Poulsen PL, Ebbehoj E, Mogensen CE. What is hypertension in diabetes? Ambulatory blood pressure in 137 normotensive and normoalbuminuric type 1 diabetic patients.  Diabet Med. 2001;  18 370-373
    CrossrefPubMedSuche in Google Scholar
  • 30 Madacsy L, Yasar A, Tulassay T, Korner A, Kelemen J, Hobor M, Miltenyi M. Relative nocturnal hypertension in children with insulin-dependent diabetes mellitus.  Acta Paediatr. 1994;  83 414-417
    PubMedSuche in Google Scholar
  • 31 Collado-Mesa F, Colhoun HM, Stevens LK, Boavida J, Ferriss JB, Karamanos B, Kempler P, Michel G, Roglic G, Fuller JH. Prevalence and management of hypertension in type 1 diabetes mellitus in Europe: the EURODIAB IDDM Complications Study.  Diabet Med. 1999;  16 41-48
    PubMedSuche in Google Scholar
  • 32 Schultz CJ, Neil HA, Dalton RN, Konopelska Bahu T, Dunger DB. Oxford Regional Prospective Study Group. Blood pressure does not rise before the onset of microalbuminuria in children followed from diagnosis of type 1 diabetes. Oxford Regional Prospective Study Group.  Diabetes Care. 2001;  24 555-560
    CrossrefPubMedSuche in Google Scholar
  • 33 Bakris GL, Williams M, Dworkin L, Elliott WJ, Epstein M, Toto R, Tuttle K, Douglas J, Hsueh W, Sowers J. Preserving renal function in adults with hypertension and diabetes: a consensus approach. National Kidney Foundation Hypertension and Diabetes Executive Committees Working Group.  Am J Kidney Dis. 2000;  36 646-661
    CrossrefPubMedSuche in Google Scholar
  • 34 Weir MR. Diabetes and hypertension: how low should you go and with which drugs?.  Am J Hypertens. 2001;  14 ((5 Pt 2)) 17S-26S
    CrossrefPubMedSuche in Google Scholar
  • 35 Wells T, Frame V, Soffer B, Shaw W, Zhang Z, Herrera P, Shahinfar S. A double-blind, placebo-controlled, dose-response study of the effectiveness and safety of enalapril for children with hypertension.  J Clin Pharmacol. 2002;  42 870-880
    CrossrefPubMedSuche in Google Scholar
  • 36 Soffer B, Zhang Z, Miller K, Vogt BA, Shahinfar S. A double-blind, placebo-controlled, dose-response study of the effectiveness and safety of lisinopril for children with hypertension.  Am J Hypertens. 2003;  16 795-800
    CrossrefPubMedSuche in Google Scholar
  • 37 Shahinfar S, Cano F, Soffer BA, Ahmed T, Santoro EP, Zhang Z, Gleim G, Miller K, Vogt B, Blumer J, Briazgounov I. A double blind, dose response study of losartan in hypertensive children.  Am J Hypertens. 2005;  18 183-190
    CrossrefPubMedSuche in Google Scholar
  • 38 Rudberg S, Aperia A, Freyschuss U, Persson B. Enalapril reduces microalbuminuria in young normotensive type 1 (insulin-dependent) diabetic patients irrespective of its hypotensive effect.  Diabetologia. 1990;  33 470-476
    CrossrefPubMedSuche in Google Scholar
  • 39 Rudberg S, Osterby R, Bangstad HJ, Dahlquist G, Persson B. Effect of angiotensin converting enzyme inhibitor or beta blocker on glomerular structural changes in young microalbuminuric patients with Type I (insulin-dependent) diabetes mellitus.  Diabetologia. 1999;  42 589-595
    CrossrefPubMedSuche in Google Scholar
  • 40 Frohlich ED, Cooper RA, Lewis EJ. Review of the overall experience of captopril in hypertension.  Arch Intern Med. 1984;  144 1441-1444
    CrossrefPubMedSuche in Google Scholar
  • 41 Mirkin BL, Newman TJ. Efficacy and safety of captopril in the treatment of severe childhood hypertension: report of the International Collaborative Study Group.  Pediatrics. 1985;  75 1091-1100
    PubMedSuche in Google Scholar
  • 42 Steinberg D. The cholesterol controversy is over.  Why did it take so long? Circulation. 1989;  80 1070-1078
    PubMedSuche in Google Scholar
  • 43 Lipid Research Clinics. The Lipid Research Clinics Coronary Primary Prevention Trial results II. The relationship of reduction in incidence of coronary heart disease to cholesterol lowering.  JAMA. 1984;  251 365-374
    CrossrefPubMedSuche in Google Scholar
  • 44 Summary of the second report of the National Cholesterol Education Program (NCEP) Expert panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) . JAMA. 2001;  285 2486-2497
    CrossrefPubMed
  • 45 Brown MS, Goldstein JL. A receptor-mediated pathway for cholesterol homeostasis.  Science. 1986;  232 34-47
    CrossrefPubMedSuche in Google Scholar
  • 46 Gould AL, Rossouw JE, Santanello NC, Heyse JF, Furberg CD. Cholesterol reduction yields clinical benefit: impact of statin trials.  Circulation. 1998;  97 946-952
    PubMedSuche in Google Scholar
  • 47 Steinberg D. Atherogenesis in perspective: hypercholesterolemia and inflammation as partners in crime.  Nature Medicine. 2002;  8 1211-1217
    CrossrefPubMedSuche in Google Scholar
  • 48 Taskinen MR. Hyperlipidemia in diabetes.  Baillieres Clin Endocrinol Metab. 1990;  4 743-775
    PubMedSuche in Google Scholar
  • 49 Pyorala K. Diabetes and heart disease. Morgensen CE, Standl E, Eds. In Prevention and Treatment of Diabetic Late Complications. New York, Walter de Gruyter 1989: 151-168
    Suche in Google Scholar
  • 50 Tomkin GH, Owens D. Insulin and lipoprotein metabolism with special reference to the diabetic state.  Diabet Metab Rev. 1994;  10 225-252
    PubMedSuche in Google Scholar
  • 51 Freedman DS, Otovs JD, Jeyarajah EJ, Barboriak JJ, Anderson AJ, Walker JA. Relation of lipoprotein subclasses as measured by proton nuclear magnetic resonance spectroscopy to coronary artery disease.  Arterioscler Thromb Vasc Biol. 1998;  18 1046-1053
    PubMedSuche in Google Scholar
  • 52 Rosenson RS, Freedman DS, Otvos JD. Relations of lipoprotein subclass levels and LDL size to progression of coronary artery disease in the PLAC I trial.  Am J Cardiol. 2002;  90 89-94
    CrossrefPubMedSuche in Google Scholar
  • 53 Mackey RH, Kuller LH, Sutton-Tyrrel K, Evans RW, Holubkov R, Matthews KA. Lipoprotein subclasses and coronary artery calcium in postmenopausal women from the Healthy Women Study.  Am J Cardiol. 2002;  90 71-76
    CrossrefPubMedSuche in Google Scholar
  • 54 Jenkins AJ, Lyons TJ, Zheng D, Otvos JD, Lackland DT, McGee D, Garvey WT, Klein RL. The DCCT/EDIC Research Group . Serum Lipoproteins in the Diabetes Control and Complications Trial /Epidemiology of Diabetes Intervention and Complication Cohort.  Diabetes Care. 2003;  26 810-818
    CrossrefPubMedSuche in Google Scholar
  • 55 Libby P, Ridker PM, Maseri A. Inflammation and atherosclerosis.  Circulation. 2002;  105 1135-1143
    CrossrefPubMedSuche in Google Scholar
  • 56 Dichtl W, Nilsson L, Goncalves I, Ares MP, Banfi C, Calara F, Hamsten A, Eriksson P, Nilsson J. Very low-density lipoprotein activates nuclear factor-kappaB in endothelial cells.  Circ Res. 1999;  84 1085-1094
    PubMedSuche in Google Scholar
  • 57 Mackness MI, Mackness B, Durrington PN, Fogelman AM, Berliner J, Lusis AJ, Navab M, Shih D, Fonarow GC. Paraoxonase and coronary heart disease.  Curr Opin Lipidol. 1998;  9 319-324
    PubMedSuche in Google Scholar
  • 58 American Academy of Pediatrics Committee of Nutrition: Cholesterol in Childhood . Pediatrics. 1998;  101 141-147
    PubMed
  • 59 Williams C, Hayman L, Daniels S, Robinson T, Steinberger J, Paridon S. Cardiovascular health in childhood: a statement for health professionals from the Committee on Atherosclerosis, Hypertension and Obesity in the Young (AHOY) of the Council on Cardiovascular Disease in the Young: American Heart Association.  Circulation. 2002;  106 143-160
    CrossrefPubMedSuche in Google Scholar
  • 60 American Diabetes Association . Position statement: treatment of hypertension in children and adolescents with diabetes.  Diabetes Care. 2003;  26 2194-2197
    CrossrefPubMedSuche in Google Scholar
  • 61 Belay B, Belamarich P, Racine AD. Pediatric precursors of adult atherosclerosis.  Pediatr Rev. 2004;  25 4-16
    PubMedSuche in Google Scholar
  • 62 Heart protection Study Collaboratory Group . MRC/BHF Heart Protection Study of cholesterol-lowering with simvastatin in 5963 people with diabetes: a randomized placebo-controlled trial.  The Lancet. 2003;  361 2005-2016
    CrossrefPubMedSuche in Google Scholar
  • 63 UK Prospective Diabetes Study Group . Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38.  BMJ. 1998;  317 703-713
    PubMedSuche in Google Scholar
  • 64 The Heart Outcomes Prevention Evaluation Study Investigators . Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients.  N Engl J Med. 2000;  342 145-153
    CrossrefPubMedSuche in Google Scholar
  • 65 UK Prospective Diabetes Study (UKPDS) Group . Intensive blood-glucose control with sulphononylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33).  Lancet. 1998;  352 837-853
    CrossrefPubMedSuche in Google Scholar
  • 66 Heart Protection Study Collaborative Group . MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20536 high-risk individuals: a randomised placebo-controlled trial.  Lancet. 2002;  360 7-22
    CrossrefPubMedSuche in Google Scholar
  • 67 Schmidt AM, Yan SD, Wautier JL, Stern D. Activation of receptor for advanced glycation end products: a mechanism for chronic vascular dysfunction in diabetic vasculopathy and atherosclerosis.  Circ Res. 1999;  84 489-497
    CrossrefPubMedSuche in Google Scholar
  • 68 Baynes JW, Thorpe SR. Role of oxidative stress in diabetic complications: a new perspective on an old paradigm.  Diabetes. 1999;  48 1-9
    CrossrefPubMedSuche in Google Scholar
  • 69 DCCT Research Group: Effect of intensive therapy on the development and progression of diabetic nephropathy in the Diabetes Control and Complications Trial . The Diabetes Control and Complications (DCCT) Research Group.  Kidney Int. 1995;  47 1703-1720
    PubMedSuche in Google Scholar
  • 70 DCCT Research Group: Progression of retinopathy with intensive versus conventional treatment in the Diabetes Control and Complications Trial . Diabetes Control and Complications Trial Research Group.  Ophthalmology. 1995;  102 647-661
    PubMedSuche in Google Scholar
  • 71 Nathan DM, Cleary PA, Backlund JY, Genuth SM, Lachin JM, Orchard TJ, Raskin P, Zinman B. Diabetes Control and Complications Trial/Epidemiology of Diabetes interventions and Complications (DCCT/EDIC) Study Research Group. Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes.  N Engl J Med. 2005;  353 2707-2709
    CrossrefPubMedSuche in Google Scholar
  • 72 Larsen J, Bergengen L, Sandvik L, Arnesen H, Hanssen KF, Dahl-Jorgensen K. Mean HbA1c during 18 years predicts common carotid artery intima-media thickness in women with diabetes type 1.  Diabetologia. 2005;  48 776-779
    CrossrefPubMedSuche in Google Scholar
  • 73 Larsen JR, Sjoholm H, Berg TJ, Sandvik L, Brekke M, Hanssen KF, Dahl-Jorgensen K. Eighteen years of fair glycemic control preserves cardiac autonomic function in type 1 diabetes.  Diabetes Care. 2004;  27 963-966
    PubMedSuche in Google Scholar
  • 74 Parikh A, Sochett EB, McCrindle BW, Dipchand A, Daneman A, Daneman D. Carotid artery distensibility and cardiac function in adolescents with type 1 diabetes.  J Pediatr. 2000;  137 465-469
    CrossrefPubMedSuche in Google Scholar
  • 75 Jensen-Urstad KJ, Reichard PG, Rosfors JS, Lindblad LE, Jensen-Urstad MT. Early atherosclerosis is retarded by improved long-term blood glucose control in patients with IDDM.  Diabetes. 1996;  45 1253-1258
    PubMedSuche in Google Scholar
  • 76 The Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research Group . Intensive Diabetes Therapy and Carotid Intima-Media Thickness in Type 1 Diabetes Mellitus.  N Eng J Med. 2003;  348 2294-2303
    CrossrefPubMedSuche in Google Scholar
  • 77 Belay B, Belamarich P, Racine AD. Pediatric precursors of adult atherosclerosis.  Pediatr Rev. 2004;  25 4-16
    PubMedSuche in Google Scholar
  • 78 Grundy SM, Balady GJ, Criqui MH, Fletcher G, Greenland P, Hiratzka LF, Houston-Miller N, Kris-Etherton P, Krumholz HM, LaRosa J, Ockene IS, Pearson TA, Reed J, Washington R, Smith Jr SC. Primary prevention of coronary heart disease: guidance from Framingham: a statement for healthcare professionals from the AHA Task Force on Risk Reduction American Heart Association.  Circulation. 1998;  97 1876-1887
    PubMedSuche in Google Scholar
  • 79 Rippin JD, Patel A, Bain SC. Genetics of diabetic nephropathy.  Best Pract Res Clin Endocrinol Metab. 2001;  15 345-358
    CrossrefPubMedSuche in Google Scholar
  • 80 Erbey JR, Kuller LH, Becker DJ, Orchard DJ. The association between a family history of type-2 diabetes and coronary artery disease in a type-1 diabetes population.  Diabetes Care. 1998;  21 610-614
    PubMedSuche in Google Scholar
  • 81 Mäkimattila S, Ylitalo K, Schlenzka A, Taskinen M-R, Summanen P, Syvänne M, Yki-Järvinen H. Family history of type-2 diabetes and hypertension predict intima-media thickness in patients with type-1 diabetes.  Diabetologia. 2002;  45 711-718
    CrossrefPubMedSuche in Google Scholar
  • 82 American Academy of Pediatrics, Committee on Nutrition: Cholesterol in children . Pediatrics. 1998;  101 141-147
    PubMed
  • 83 Deckelbaum RJ, Williams CL. Childhood obesity: The health issue.  Obes Res. 2001;  9 ((Suppl 4)) 239-243
    PubMedSuche in Google Scholar
  • 84 Rocchini AP. Childhood obesity and diabetes epidemic.  N Eng J Med. 2002;  346 854-855
    CrossrefPubMedSuche in Google Scholar
  • 85 Dietz WH, Robinson TN. Use of body mass index (BMI) to assess obesity in children.  Am J Clin Nutr. 1999;  70 S123-S125
    PubMedSuche in Google Scholar
  • 86 Ogden CL, Flegal KM, Carroll MD, Johnson CL. Prevalence and trends in overweight among US children and adolescents 1999-2000.  JAMA. 2002;  288 1728-1732
    CrossrefPubMedSuche in Google Scholar
  • 87 Caprio S, Tamborlane WV. Metabolic impact of obesity in childhood.  Endocrinol Metab Clin North Am. 1999;  28 731-747
    CrossrefPubMedSuche in Google Scholar
  • 88 Koivisto VA, Stevens LK, Mattock M, Ebeling P, Muggeo M, Stephenson J, Idzior-Walus B. The EURODIAB IDDM Complications. Study Group. Cardiovascular disease and its risk factors in IDDM in Europe.  Diabetes Care. 1996;  19 689-697
    CrossrefPubMedSuche in Google Scholar
  • 89 Caprio S, Bronson M, Sherwin RS, Rife F, Tamborlane WV. Co-existence of severe insulin resistance and hyperinsulinaemia in pre-adolescent obese children.  Diabetologia. 1996;  39 1489-1497
    CrossrefPubMedSuche in Google Scholar
  • 90 Tchernof A, Nolan A, Sites CK, Ades PA, Poehlman ET. Weight loss reduces C-reactive protein levels in obese postmenopausal women.  Circulation. 2002;  105 564-569
    CrossrefPubMedSuche in Google Scholar
  • 91 Hamdy O, Ledbury S, Mullooly C, Jarema C, Porter S, Ovalle K, Moussa A, Caselli A, Caballero AE, Economides PA, Veves A, Horton ES. Lifestyle modification improves endothelial function in obese subjects with the insulin resistance syndrome.  Diabetes Care. 2003;  26 2119-2125
    CrossrefPubMedSuche in Google Scholar
  • 92 Brown AA, Hu FB. Dietary modulation of endothelial function: implications for cardiovascular disease.  Am J Clin Nutr. 2001;  73 673-686
    PubMedSuche in Google Scholar
  • 93 Mezzano D, Leighton F, Martinez C, Marshall G, Cuevas A, Castillo O, Panes O, Munoz B, Perez DD, Mizon C, Rozowski J, San Martin A, Pereira J. Complementary effects of Mediterranean diet and moderate red wine intake on haemostatic cardiovascular risk factors.  Eur J Clin Nutr. 2001;  55 444-451
    CrossrefPubMedSuche in Google Scholar
  • 94 Etherton PK, Eckel RH, Howard BV, Jeor S, Bazzarre TL. Lyon Diet Heart Study: Benefits of a Mediterranean-Style, National Cholesterol Education Program/American Hearth Association Step I Dietary Pattern on Cardiovascular Disease.  Circulation. 2001;  103 1823-1825
    PubMedSuche in Google Scholar
  • 95 Fuentes F, Lopez-Miranda J, Sanchez E, Sanchez F, Paez J, Paz-Rojas E, Marin C, Gomez P, Jimenez-Pereperez J, Ordovas JM, Perez-Jimenez F. Mediterranean and low-fat diets improve endothelial function in hypercholesterolemic men.  Ann Intern Med. 2001;  134 1115-1119
    PubMedSuche in Google Scholar
  • 96 Jenkins DJ, Kendall CW, Marchie A, Faulkner DA, Wong JM, de Souza R, Emam A, Parker TL, Vidgen E, Lapsley KG, Trautwein EA, Josse RG, Leiter LA, Connelly PW. Effects of a dietary portfolio of cholesterol-lowering foods vs lovastatin on serum lipids and C-reactive protein.  JAMA. 2003;  290 502-510
    CrossrefPubMedSuche in Google Scholar
  • 97 Kuczmarski RJ, Ogden CL, Guo SS, Grummer-Strawn LM, Flegal KM, Mei Z, Wei R, Curtin LR, Roche AF, Johnson CL. 2000 CDC Growth Charts for the United States: methods and development.  Vital Health Stat. 11;  2002 1-190
    PubMedSuche in Google Scholar
  • 98 Yudkin JS, Stehouwer CD, Emeis JJ, Coppack SW. C-reactive protein in healthy subjects: associations with obesity, insulin resistance, and endothelial dysfunction: a potential role for cytokines originating from adipose tissue?.  Arterioscler Thromb Vasc Biol. 1999;  19 972-978
    CrossrefPubMedSuche in Google Scholar
  • 99 Caprio S, Hyman LD, Limb C. et al . Central adiposity and its metabolic correlates in obese adolescents girls.  Am J Physiol. 1995;  269 E118-E126
    PubMedSuche in Google Scholar
  • 100 Sinha R, Fisch G, Teague B. et al . Prevalence of impaired glucose tolerance among children and adolescents with marked obesity.  N Engl J Med. 2002;  346 802-810
    CrossrefPubMedSuche in Google Scholar
  • 101 Freedman DS, William H, Dietz WH, Sathanur R, Srinivasan SR, Berenson GS. The Relation of Overweight to Cardiovascular Risk Factors Among Children and Adolescents: The Bogalusa Heart Study.  Pediatrics. 1999;  103 1175-1182
    CrossrefPubMedSuche in Google Scholar
  • 102 Woo KS, Chook P, Yu CW, Sung RY, Qiao M, Leung SS, Lam CW, Metreweli C, Celermajer DS. Overweight in children is associated with arterial endothelial dysfunction and intima-media thickening.  Int J Obes Relat Metab Disord. 2004;  28 852-857
    CrossrefPubMedSuche in Google Scholar
  • 103 Czernin J, Waldherr C. Cigarette smoking and coronary blood flow.  Prog Cardiovasc Dis. 2003;  45 395-404
    PubMedSuche in Google Scholar
  • 104 Tamer L, Ercan B, Camsari A, Yildirim H, Cicek D, Sucu N, Ates NA, Atik U. Glutathione S-transferase gene polymorphism as a susceptibility factor in smoking-related coronary artery disease.  Basic Res Cardiol. 2004;  99 223-229 , Epub 2004 Feb 16
    CrossrefPubMedSuche in Google Scholar
  • 105 Masetti S, Botto N, Manfredi S, Colombo MG, Rizza A, Vassalle C, Clerico A, Biagini A, Andreassi MG. Interactive effect of the glutathione S-transferase genes and cigarette smoking on occurrence and severity of coronary artery risk.  J Mol Med. 2003;  81 488-494 , Epub 2003 Jun 17
    CrossrefPubMedSuche in Google Scholar
  • 106 Ford ES, Malarcher AM, Herman WH, Aubert RE. Diabetes mellitus and cigarette smoking. Findings from the 1989 National Health Interview Survey.  Diabetes Care. 1994;  17 688-692
    PubMedSuche in Google Scholar
  • 107 Masson EA, MacFarlane IA, Priestly CJ, Wallymahmed ME, Flavell HJ. Failure to prevent nicotine addiction in young people with diabetes.  Arch Dis Child. 1992;  67 100-102
    PubMedSuche in Google Scholar
  • 108 Shaw NJ, McClure RJ, Kerr S, Lawton K, Smith CS. Smoking in diabetic teenagers.  Diabet Med. 1993;  10 255-257
    PubMedSuche in Google Scholar
  • 109 DeFronzo RA. Lilly lecture 1987. The triumvirate: beta-cell, muscle, liver. A collusion responsible for NIDDM.  Diabetes. 1988;  37 667-687
    CrossrefPubMedSuche in Google Scholar
  • 110 Lillioja S, Mott DM, Spraul M, Ferraro R, Foley JE, Ravussin E, Knowler WC, Bennett PH, Bogardus C. Insulin resistance and insulin secretory dysfunction as precursors of non-insulin-dependent diabetes mellitus. Prospective studies of Pima Indians.  N Engl J Med. 1993;  329 1988-1992
    CrossrefPubMedSuche in Google Scholar
  • 111 Helmrich SP, Ragland DR, Leung RW, Paffenbarger Jr RS. Physical activity and reduced occurrence of non-insulin-dependent diabetes mellitus.  N Engl J Med. 1991;  325 147-152
    CrossrefPubMedSuche in Google Scholar
  • 112 Helmrich SP, Ragland DR, Paffenbarger Jr RS. Prevention of non-insulin-dependent diabetes mellitus with physical activity.  Med Sci Sports Exerc. 1994;  26 824-830
    PubMedSuche in Google Scholar
  • 113 Mayer-Davis EJ, D'Agostino Jr R, Karter AJ, Haffner SM, Rewers MJ, Saad M, Bergman RN. Intensity and amount of physical activity in relation to insulin sensitivity: the Insulin Resistance Atherosclerosis Study.  JAMA. 1998;  279 669-674
    CrossrefPubMedSuche in Google Scholar
  • 114 Wannamethee SG, Shaper AG, Alberti KG. Physical activity, metabolic factors, and the incidence of coronary heart disease and Type 2 diabetes.  Arch Intern Med. 2000;  160 2108-2116
    CrossrefPubMedSuche in Google Scholar
  • 115 Gokce N, Vita JA, Bader DS, Sherman DL, Hunter LM, Holbrook M, O'Malley C, Keaney Jr JF, Balady GJ. Effect of exercise on upper and lower extremity endothelial function in patients with coronary artery disease.  Am J Cardiol. 2002;  90 124-127
    CrossrefPubMedSuche in Google Scholar
  • 116 Maiorana A, O'Driscoll G, Cheetham C, Dembo L, Stanton K, Goodman C, Taylor R, Green D. The effect of combined aerobic and resistance exercise training on vascular function in type 2 diabetes.  J Am Coll Cardiol. 2001;  38 860-866
    CrossrefPubMedSuche in Google Scholar
  • 117 Hambrecht R, Wolf A, Gielen S, Linke A, Hofer J, Erbs S, Schoene N, Schuler G. Effect of exercise on coronary endothelial function in patients with coronary artery disease.  N Engl J Med. 2000;  342 454-460
    CrossrefPubMedSuche in Google Scholar
  • 118 Wei M, Gibbons LW, Kampert JB, Nichaman MZ, Blair SN. Low cardiorespiratory fitness and physical inactivity as predictors of mortality in men with Type 2 diabetes.  Ann Intern Med. 2000;  132 605-611
    PubMedSuche in Google Scholar
  • 119 Williams CL, Hayman LL, Daniels SR, Robinson TN, Steinberger J, Paridon S, Bazzarre T. Cardiovascular health in childhood: A statement for health professionals from the Committee on Atheroscerosis, Hypertension, and Obesity in the Young (AHOY) of the Council on Cardiovascular Disease in the Young, American Heart Association.  Circulation. 2002;  106 143-160
    CrossrefPubMedSuche in Google Scholar
  • 120 Woo KS, Chook P, Yu CW, Sung RY, Qiao M, Leung SS, Lam CW, Metreweli C, Celermajer DS. Effects of diet and exercise on obesity-related vascular dysfunction in children.  Circulation. 2004;  109 1981-1986
    CrossrefPubMedSuche in Google Scholar
  • 121 Moy CS, Songer TJ, LaPorte R. et al . Insulin-dependent diabetes mellitus, physical activity, and death.  Am J Epidemiol. 1993;  137 74-81
    PubMedSuche in Google Scholar
  • 122 Kriska AM, LaPorte RE, Patrick SL, Kuller LH, Orchard TJ. The association of physical activity and diabetic complications in individuals with insulin-dependent diabetes mellitus: the Epidemiology of Diabetes Complications Study VII.  J Clin Epidemiol. 1991;  44 1207-1214
    CrossrefPubMedSuche in Google Scholar
  • 123 Wallberg-Henriksson H, Gunnarson R, Henriksson J. et al . Increased peripheral insulin sensitivity and muscle mitochondrial enzymes but unchanged blood glucose control in type-1 diabetics after physical training.  Diabetes. 1982;  31 1044-1050
    PubMedSuche in Google Scholar
  • 124 Rowland T, Swadba LA, Biggs DE, Burke EJ, Reiter EO. Glycemic control with physical training in insulin-dependent diabetes mellitus.  Sports Med. 1985;  139 307-310
    PubMedSuche in Google Scholar
  • 125 Sobel BE. Insulin resistance and thrombosis: a cardiologist's view.  Am J Cardiol. 1999;  84 37-41
    PubMedSuche in Google Scholar
  • 126 Nordt TK, Bode C. Impaired endogenous fibrinolysis in diabetes mellitus: mechanisms and therapeutic approaches.  Semin Thromb Hemost. 2000;  26 495-501
    Thieme ConnectPubMedSuche in Google Scholar
  • 127 Smith FB, Fowkes FG, Rumley A, Lee AJ, Lowe GD, Hau CM. Tissue plasminogen activator and leucocyte elastase as predictors of cardiovascular events in subjects with angina pectoris: Edinburgh Artery Study.  Eur Heart J. 2000;  21 1607-1613
    CrossrefPubMedSuche in Google Scholar
  • 128 Thogersen AM, Jansson JH, Boman K, Nilsson TK, Weinehall L, Huhtasaari F, Hallmans G. High plasminogen activator inhibitor and tissue plasminogen activator levels in plasma precede a first acute myocardial infarction in both men and women: evidence for the fibrinolytic system as an independent primary risk factor.  Circulation. 1998;  98 2241-2247
    CrossrefPubMedSuche in Google Scholar
  • 129 Wieczorek I, Ludlam CA, Fox KA. Tissue-type plasminogen activator and plasminogen activator inhibitor activities as predictors of adverse events in unstable angina.  Am J Cardiol. 1994;  74 424-429
    CrossrefPubMedSuche in Google Scholar
  • 130 Huber K, Christ G, Wojta J, Gulba D. Plasminogen activator inhibitor type-1 in cardiovascular disease. Status report 2001.  Thromb Res. 2001;  103 ((Suppl 1)) S7-S19
    CrossrefPubMedSuche in Google Scholar
  • 131 Haffner SM, D'Agostino Jr R, Mykkanen L, Tracy R, Howard B, Rewers M, Selby J, Savage PJ, Saad MF. Insulin sensitivity in subjects with type 2 diabetes. Relationship to cardiovascular risk factors: the Insulin Resistance Atherosclerosis Study.  Diabetes Care. 1999;  22 562-568
    PubMedSuche in Google Scholar
  • 132 Meigs JB, Mittleman MA, Nathan DM, Tofler GH, Singer DE, Murphy-Sheehy PM, Lipinska I, D'Agostino RB, Wilson PW. Hyperinsulinemia, hyperglycemia, and impaired hemostasis: The Framingham Offspring Study.  JAMA. 2000;  283 221-228
    CrossrefPubMedSuche in Google Scholar
  • 133 Sobel BE. Coronary artery disease and fibrinolysis: from the blood to the vessel wall.  Thromb Haemost. 1999;  82 ((Suppl 1)) 8-13
    PubMedSuche in Google Scholar
  • 134 Calles-Escandon J, Mirza SA, Sobel BE, Schneider DJ. Induction of hyperinsulinemia combined with hyperglycemia and hypertriglyceridemia increases plasminogen activator inhibitor 1 in blood in normal human subjects.  Diabetes. 1998;  47 290-293
    PubMedSuche in Google Scholar
  • 135 Anand SS, Yi Q, Gerstein H, Lonn E, Jacobs R, Vuksan V, Teo K, Davis B, Montague P, Yusuf S. Relationship of metabolic syndrome and fibrinolytic dysfunction to cardiovascular disease.  Circulation. 2003;  108 420-425
    CrossrefPubMedSuche in Google Scholar
  • 136 American Diabetes Association . Position Statement. Aspirin therapy in diabetes.  Diabetes Care. 2003;  26 ((Suppl 1)) S87-S88
    PubMedSuche in Google Scholar
  • 137 Adler AI, Stevens RJ, Neil A, Stratton IM, Boulton AJ, Holman RR. UKPDS 59: hyperglycemia and other potentially modifiable risk factors for peripheral vascular disease in type 2 diabetes.  Diabetes Care. 2002;  25 894-899
    CrossrefPubMedSuche in Google Scholar
  • 138 Stamler J, Vaccaro O, Neaton JD, Wentworth D. Diabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial.  Diabetes Care. 1993;  16 434-444
    CrossrefPubMedSuche in Google Scholar
  • 139 Fonseca VA. Risk factors for coronary heart disease in diabetes.  Ann Intern Med. 2000;  133 154-156
    PubMedSuche in Google Scholar
  • 140 Saito I, Folsom AR, Brancati FL, Duncan BB, Chambless LE, McGovern PG. Nontraditional risk factors for coronary heart disease incidence among persons with diabetes: the Atherosclerosis Risk in Communities (ARIC) Study.  Ann Intern Med. 2000;  133 81-91
    PubMedSuche in Google Scholar
  • 141 Jialal I, Stein D, Balis D, Grundy SM, Adams-Huet B, Devaraj S. Effect of hydroxymethyl glutaryl coenzyme a reductase inhibitor therapy on high sensitive C-reactive protein levels.  Circulation. 2001;  103 1933-1935
    PubMedSuche in Google Scholar
  • 142 Calles-Escandon J, Cipolla M. Diabetes and endothelial dysfunction: a clinical perspective.  Endocr Rev. 2001;  22 36-52
    CrossrefPubMedSuche in Google Scholar
  • 143 Schachinger V, Britten MB, Zeiher AM. Prognostic impact of coronary vasodilator dysfunction on adverse long-term outcome of coronary heart disease.  Circulation. 2000;  101 1899-1906
    CrossrefPubMedSuche in Google Scholar
  • 144 Quyyumi AA. Endothelial function in health and disease: new insights into the genesis of cardiovascular disease.  Am J Med. 1998;  105 32S-39S
    PubMedSuche in Google Scholar
  • 145 Kuvin JT, Karas RH. Clinical utility of endothelial function testing: ready for prime time?.  Circulation. 2003;  107 3243-3247
    CrossrefPubMedSuche in Google Scholar
  • 146 Williams SB, Cusco JA, Roddy MA, Johnstone MT, Creager MA. Impaired nitric oxide-mediated vasodilation in patients with non-insulin-dependent diabetes mellitus.  J Am Coll Cardiol. 1996;  27 567-574
    CrossrefPubMedSuche in Google Scholar
  • 147 Williams SB, Goldfine AB, Timimi FK, Ting HH, Roddy MA, Simonson DC, Creager MA. Acute hyperglycemia attenuates endothelium-dependent vasodilation in humans in vivo.  Circulation. 1998;  97 1695-1701
    CrossrefPubMedSuche in Google Scholar
  • 148 Baron AD. Insulin resistance and vascular function.  J Diabetes Complications. 2002;  16 92-102
    CrossrefPubMedSuche in Google Scholar
  • 149 Baron AD, Steinberg HO. Endothelial function, insulin sensitivity, and hypertension.  Circulation. 1997;  96 725-726
    PubMedSuche in Google Scholar
  • 150 Baron AD. Insulin and the vasculature-old actors, new roles.  J Investig Med. 1996;  44 406-412
    PubMedSuche in Google Scholar
  • 151 Steinberg HO, Chaker H, Leaming R, Johnson A, Brechtel G, Baron AD. Obesity/insulin resistance is associated with endothelial dysfunction. Implications for the syndrome of insulin resistance.  J Clin Invest. 1996;  97 2601-2610
    CrossrefPubMedSuche in Google Scholar
  • 152 Steinberg HO, Paradisi G, Hook G, Crowder K, Cronin J, Baron AD. Free fatty acid elevation impairs insulin-mediated vasodilation and nitric oxide production.  Diabetes. 2000;  49 1231-1238
    PubMedSuche in Google Scholar
  • 153 Grover A, Padginton C, Wilson MF, Sung BH, Izzo Jr JL, Dandona P. Insulin attenuates norepinephrine-induced venoconstriction. An ultrasonographic study.  Hypertension. 1995;  25 779-784
    PubMedSuche in Google Scholar
  • 154 Aljada A, Dandona P. Effect of insulin on human aortic endothelial nitric oxide synthase.  Metabolism. 2000;  49 147-150
    CrossrefPubMedSuche in Google Scholar
  • 155 Aljada A, Ghanim H, Assian E, Dandona P. Tumor necrosis factor-α inhibits insulin-induced increase in endothelial nitric oxide synthase and reduces insulin receptor content and phosphorylation in human aortic endothelial cells.  Metabolism. 2002;  51 487-491
    CrossrefPubMedSuche in Google Scholar
  • 156 Zeng G, Quon MJ. Insulin-stimulated production of nitric oxide is inhibited by wortmannin. Direct measurement in vascular endothelial cells.  J Clin Invest. 1996;  98 894-898
    CrossrefPubMedSuche in Google Scholar
  • 157 Fonseca V, Desouza C, Asnani S, Jialal I. Nontraditional Risk Factors for Cardiovascular Disease in Diabetes.  Endocrine Reviews. 2004;  25 153-175
    CrossrefPubMedSuche in Google Scholar
  • 158 Feener EP, King GL. Vascular dysfunction in diabetes mellitus.  Lancet. 1997;  350 ((Suppl 1)) SI9-S13
    PubMedSuche in Google Scholar
  • 159 Zeng G, Nystrom FH, Ravichandran LV, Cong LN, Kirby M, Mostowski H, Quon MJ. Roles for insulin receptor, PI3-kinase, and Akt in insulin-signaling pathways related to production of nitric oxide in human vascular endothelial cells.  Circulation. 2000;  101 1539-1545
    CrossrefPubMedSuche in Google Scholar
  • 160 Montagnani M, Golovchenko I, Kim I, Koh GY, Goalstone ML, Mundhekar AN, Johansen M, Kucik DF, Quon MJ, Draznin B. Inhibition of phosphatidylinositol 3-kinase enhances mitogenic actions of insulin in endothelial cells.  J Biol Chem. 2002;  277 1794-1799
    CrossrefPubMedSuche in Google Scholar
  • 161 Kuboki K, Jiang ZY, Takahara N, Ha SW, Igarashi M, Yamauchi T, Feener EP, Herbert TP, Rhodes CJ, King GL. Regulation of endothelial constitutive nitric oxide synthase gene expression in endothelial cells and in vivo: a specific vascular action of insulin.  Circulation. 2000;  101 676-681
    PubMedSuche in Google Scholar
  • 162 Cooke JP. Does ADMA cause endothelial dysfunction?.  Arterioscler Thromb Vasc Biol. 2000;  20 2032-2037
    CrossrefPubMedSuche in Google Scholar
  • 163 Eid HM, Eritsland J, Larsen J, Arnesen H, Seljeflot I. Increased levels of asymmetric dimethylarginine in populations at risk for atherosclerotic disease. Effects of pravastatin.  Atherosclerosis. 2003;  166 279-284
    CrossrefPubMedSuche in Google Scholar
  • 164 Katusic ZS. Vascular endothelial dysfunction: does tetrahydrobiopterin play a role?.  Am J Physiol. 2001;  281 H981-H986
    PubMedSuche in Google Scholar
  • 165 Shinozaki K, Nishio Y, Okamura T, Yoshida Y, Maegawa H, Kojima H, Masada M, Toda N, Kikkawa R, Kashiwagi A. Oral administration of tetrahydrobiopterin prevents endothelial dysfunction and vascular oxidative stress in the aortas of insulin-resistant rats.  Circ Res. 2000;  87 566-573
    PubMedSuche in Google Scholar
  • 166 Pieper GM. Acute amelioration of diabetic endothelial dysfunction with a derivative of the nitric oxide synthase cofactor, tetrahydrobiopterin.  J Cardiovasc Pharmacol. 1997;  29 8-15
    CrossrefPubMedSuche in Google Scholar
  • 167 Ridker PM. Evaluating novel cardiovascular risk factors: can we better predict heart attacks?.  Ann Intern Med. 1999;  130 933-937
    PubMedSuche in Google Scholar
  • 168 Ridker PM, Stampfer MJ, Rifai N. Novel risk factors for systemic atherosclerosis: a comparison of C-reactive protein, fibrinogen, homocysteine, lipoprotein(a), and standard cholesterol screening as predictors of peripheral arterial disease.  JAMA. 2001;  285 2481-2485
    CrossrefPubMedSuche in Google Scholar
  • 169 Rifai N, Ridker PM. High-sensitivity C-reactive protein: a novel and promising marker of coronary heart disease.  Clin Chem. 2001;  47 403-411
    PubMedSuche in Google Scholar
  • 170 Jialal I, Devaraj S. Inflammation and atherosclerosis: the value of the high-sensitivity C-reactive protein assay as a risk marker.  Am J Clin Pathol. 2001;  116 ((Suppl)) S108-S115
    PubMedSuche in Google Scholar
  • 171 Burke AP, Tracy RP, Kolodgie F, Malcom GT, Zieske A, Kutys R, Pestaner J, Smialek J, Virmani R. Elevated C-reactive protein values and atherosclerosis in sudden coronary death: association with different pathologies.  Circulation. 2002;  105 2019-2023
    CrossrefPubMedSuche in Google Scholar
  • 172 Ridker PM, Buring JE, Shih J, Matias M, Hennekens CH. Prospective study of C-reactive protein and the risk of future cardiovascular events among apparently healthy women.  Circulation. 1998;  98 731-733
    CrossrefPubMedSuche in Google Scholar
  • 173 Rohde LE, Hennekens CH, Ridker PM. Survey of C-reactive protein and cardiovascular risk factors in apparently healthy men.  Am J Cardiol. 1999;  84 1018-1022
    CrossrefPubMedSuche in Google Scholar
  • 174 Tracy RP, Lemaitre RN, Psaty BM, Ives DG, Evans RW, Cushman M, Meilahn EN, Kuller LH. Relationship of C-reactive protein to risk of cardiovascular disease in the elderly. Results from the Cardiovascular Health Study and the Rural Health Promotion Project.  Arterioscler Thromb Vasc Biol. 1997;  17 1121-1127
    PubMedSuche in Google Scholar
  • 175 Roivainen M, Viik-Kajander M, Palosuo T, Toivanen P, Leinonen M, Saikku P, Tenkanen L, Manninen V, Hovi T, Manttari M. Infections, inflammation, and the risk of coronary heart disease.  Circulation. 2000;  101 252-257
    PubMedSuche in Google Scholar
  • 176 Verma S, Wang CH, Li SH, Dumont AS, Fedak PWM, Badiwala MV, Dhillon B, Weisel RD, Li RK, Mickle DAG, Stewart DJ. A self-fulfilling prophecy: C-reactive protein attenuates nitric oxide production and inhibits angiogenesis.  Circulation. 2002;  106 913-919
    CrossrefPubMedSuche in Google Scholar
  • 177 Venugopal SK, Devaraj S, Yuhanna I, Shaul P, Jialal I. Demonstration that C-reactive protein decreases eNOS expression and bioactivity in human aortic endothelial cells.  Circulation. 2002;  106 1439-1441
    CrossrefPubMedSuche in Google Scholar
  • 178 Dandona P, Weinstock R, Thusu K, Abdel-Rahman E, Aljada A, Wadden T. Tumor necrosis factor- in sera of obese patients: fall with weight loss.  J Clin Endocrinol Metab. 1998;  83 2907-2910
    CrossrefPubMedSuche in Google Scholar
  • 179 Mohanty P, Hamouda W, Garg R, Aljada A, Ghanim H, Dandona P. Glucose challenge stimulates reactive oxygen species (ROS) generation by leukocytes.  J Clin Endocrinol Metab. 2000;  85 2970-2973
    CrossrefPubMedSuche in Google Scholar
  • 180 Fonseca V, Guba SC, Fink LM. Hyperhomocysteinemia and the endocrine system: implications for atherosclerosis and thrombosis.  Endocr Rev. 1999;  20 738-759
    CrossrefPubMedSuche in Google Scholar
  • 181 Kark JD, Selhub J, Bostom A, Adler B, Rosenberg IH. Plasma homocysteine and all-cause mortality in diabetes.  Lancet. 1993;  53 1936-1937
    PubMedSuche in Google Scholar
  • 182 Kark JD, Selhub J, Adler B, Gofin J, Abramson JH, Friedman G, Rosenberg IH. Nonfasting plasma total homocysteine level and mortality in middle-aged and elderly men and women in Jerusalem.  Ann Intern Med. 1999;  131 321-330
    PubMedSuche in Google Scholar
  • 183 Hoogeveen EK, Kostense PJ, Beks PJ, Mackaay AJ, Jakobs C, Bouter LM, Heine RJ, Stehouwer CD. Hyperhomocysteinemia is associated with an increased risk of cardiovascular disease, especially in non-insulin-dependent diabetes mellitus: a population-based study.  Arterioscler Thromb Vasc Biol. 1998;  18 133-138
    PubMedSuche in Google Scholar
  • 184 Hoogeveen EK, Kostense PJ, Jakobs C, Dekker JM, Nijpels G, Heine RJ, Bouter LM, Stehouwer CDA. Hyperhomocysteinemia increases risk of death, especially in type 2 diabetes: 5-year follow-up of the Hoorn Study.  Circ Res. 2000;  101 1506-1511
    PubMedSuche in Google Scholar
  • 185 Munshi MN, Stone A, Fink L, Fonseca V. Hyperhomocysteinemia following a methionine load in patients with non-insulin-dependent diabetes mellitus and macrovascular disease.  Metabolism. 1996;  45 133-135
    CrossrefPubMedSuche in Google Scholar
  • 186 Tawakol A, Omland T, Gerhard M, Wu JT, Creager MA. Hyperhomocyst(e)inemia is associated with impaired endothelium-dependent vasodilation in humans.  Circ Res. 1997;  95 1119-1121
    PubMedSuche in Google Scholar
  • 187 Tan KC, Karmin O, Chow WS, Ai VH, Siow YL, Lam KS. Hyperhomocysteinemia and impaired vasomotor function in type 2 diabetes mellitus.  Eur J Clin Invest. 2002;  32 328-334
    CrossrefPubMedSuche in Google Scholar
  • 188 Jager A, Kostense PJ, Nijpels G, Dekker JM, Heine RJ, Bouter LM, Donker AJ, Stehouwer CD. Serum homocysteine levels are associated with the development of (micro)albuminuria: The Hoorn Study.  Arterioscler Thromb Vasc Biol. 2001;  21 74-81
    PubMedSuche in Google Scholar
  • 189 Hoogeveen EK, Kostense PJ, Jager A, Heine RJ, Jakobs C, Bouter LM, Donker AJ, Stehouwer CD. Serum homocysteine level and protein intake are related to risk of microalbuminuria: The Hoorn Study.  Kidney Int. 1998;  54 203-209
    PubMedSuche in Google Scholar
  • 190 Chico A, Perez A, Cordoba A, Arcelus R, Carreras G, de Leiva, Gonzalez-Sastre F, Blanco-Vaca F. Plasma homocysteine is related to albumin excretion rate in patients with diabetes mellitus: a new link between diabetic nephropathy and cardiovascular disease?.  Diabetologia. 1998;  41 684-693
    CrossrefPubMedSuche in Google Scholar
  • 191 Fonseca V, Keebler M, Dicker-Brown A, Desouza C, Poirier LA, Murthy SN, McNamara DB. The effect of troglitazone on plasma homocysteine, hepatic and red blood cell S-adenosyl methionine, and S-adenosyl homocysteine and enzymes in homocysteine metabolism in Zucker rats.  Metabolism. 2002;  51 783-786
    CrossrefPubMedSuche in Google Scholar
  • 192 Meigs JB, Jacques PF, Selhub J, Singer DE, Nathan DM, Rifai N, D'Agostino Sr RB, Wilson PW. Fasting plasma homocysteine levels in the insulin resistance syndrome: the Framingham offspring study.  Diabetes Care. 2001;  24 1403-1410
    PubMedSuche in Google Scholar
  • 193 Fonseca VA, Mudaliar S, Schmidt B, Fink LM, Kern PA, Henry RR. Plasma homocysteine concentrations are regulated by acute hyperinsulinemia in nondiabetic but not type 2 diabetic subjects.  Metabolism. 1998;  47 686-689
    CrossrefPubMedSuche in Google Scholar
  • 194 Bokemark L, Wikstrand J, Wedel H, Fagerberg B. Insulin, insulin propeptides and intima-media thickness in the carotid artery in 58-year-old clinically healthy men. The Atherosclerosis and Insulin Resistance study (AIR).  Diabet Med. 2002;  19 144-151
    CrossrefPubMedSuche in Google Scholar
  • 195 Hedblad B, Nilsson P, Janzon L, Berglund G. Relation between insulin resistance and carotid intima-media thickness and stenosis in non-diabetic subjects. Results from a cross-sectional study in Malmo, Sweden.  Diabet Med. 2000;  17 299-307
    CrossrefPubMedSuche in Google Scholar
  • 196 Niskanen L, Rauramaa R, Miettinen H, Haffner SM, Mercuri M, Uusitupa M. Carotid artery intima-media thickness in elderly patients with NIDDM and in nondiabetic subjects.  Stroke. 1996;  27 1986-1992
    PubMedSuche in Google Scholar
  • 197 Bonora E, Tessari R, Micciolo R, Zenere M, Targher G, Padovani R, Falezza G, Muggeo M. Intimal-medial thickness of the carotid artery in nondiabetic and NIDDM patients. Relationship with insulin resistance.  Diabetes Care. 1997;  20 627-631
    PubMedSuche in Google Scholar
  • 198 Stein JH, Douglas PS, Srinivasan SR, Bond MG, Tang R, Li S, Chen W, Berenson GS. Distribution and cross-sectional age-related increases of carotid artery intima-media thicknessin young adults: the Bongalusa Heart Study.  Stroke. 2004;  35 2782-2787
    CrossrefPubMedSuche in Google Scholar
  • 199 Howard G, O'Leary DH, Zaccaro D, Haffner S, Rewers M, Hamman R, Selby JV, Saad MF, Savage P, Bergman R. Insulin sensitivity and atherosclerosis. The Insulin Resistance Atherosclerosis Study (IRAS) Investigators.  Circulation. 1996;  93 1809-1817
    PubMedSuche in Google Scholar
  • 200 Hsueh WA, Law RE. Insulin signaling in the arterial wall.  Am J Cardiol. 1999;  84 21J-24J
    CrossrefPubMedSuche in Google Scholar
  • 201 O'Leary DH, Polak JF, Kronmal RA, Manolio TA, Burke GL, Wolfson SKJ. Carotid-artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults. Cardiovascular Health Study Collaborative Research Group.  N Engl J Med. 1999;  340 14-22
    CrossrefPubMedSuche in Google Scholar
  • 202 Jarvasalo MJ, Raitakari M, Troikka JO, Putto-Laurila A, Rontu R, Laine S, Lehtimaki T, Ronnemaa T, Viikari J, Raitakari OT. Endothelial dysfunction and increased arterial intima-media thickness in children with Type 1 diabetes.  Circulation. 2004;  109 1750-1755
    CrossrefPubMedSuche in Google Scholar
  • 203 Lehmann ED, Riley WA, Clarkson P, Gosling RG. Non-invasive assessment of cardiovascular disease in diabetes mellitus.  Lancet. 1997;  350 ((Suppl 1)) S114-S119
    PubMedSuche in Google Scholar
  • 204 Schram MT, Kostense PJ, Van Dijk RA, Dekker JM, Nijpels G, Bouter LM, Heine RJ, Stehouwer CD. Diabetes, pulse pressure and cardiovascular mortality: The Hoorn Study.  J Hypertens. 2002;  20 1743-1751
    CrossrefPubMedSuche in Google Scholar
  • 205 Iannuzzi A, Licenziati MR, Acampora C, Salvatore V, Auriemma L, RomanoML, Panico S, Rubba P, Trevisan M. Increased carotid intima-media thickness in obese children.  Diabetes Care. 2004;  27 2506-2508
    CrossrefPubMedSuche in Google Scholar
  • 206 Franklin SS, Khan SA, Wong ND, Larson MG, Levy D. Is pulse pressure useful in predicting risk for coronary heart disease? The Framingham Heart Study.  Circulation. 1999;  100 354-360
    PubMedSuche in Google Scholar
  • 207 McVeigh G, Brennan G, Hayes R, Cohn J, Finkelstein S, Johnston D. Vascular abnormalities in non-insulin-dependent diabetes mellitus identified by arterial waveform analysis.  Am J Med. 1993;  95 424-430
    CrossrefPubMedSuche in Google Scholar
  • 208 Emoto M, Nishizawa Y, Kawagishi T, Maekawa K, Hiura Y, Kanda H, Izumotani K, Shoji T, Ishimura E, Inaba M, Okuno Y, Morii H. Stiffness indexes β of the common carotid and femoral arteries are associated with insulin resistance in NIDDM.  Diabetes Care. 1998;  21 1178-1182
    PubMedSuche in Google Scholar
  • 209 Salomaa V, Riley W, Kark JD, Nardo C, Folsom AR. Non-insulin-dependent diabetes mellitus and fasting glucose and insulin concentrations are associated with arterial stiffness indexes. The Atherosclerosis Risk in Communities (ARIC) Study.  Circulation. 1995;  91 1432-1443
    CrossrefPubMedSuche in Google Scholar
  • 210 Taniwaki H, Kawagishi T, Emoto M, Shoji T, Kanda H, Maekawa K, Nishizawa Y, Morii H. Correlation between the intima-media thickness of the carotid artery and aortic pulse-wave velocity in patients with type 2 diabetes. Vessel wall properties in type 2 diabetes.  Diabetes Care. 1999;  22 1851-1857
    PubMedSuche in Google Scholar
  • 211 Kuvin JT, Patel AR, Sliney KA, Pandian NG, Sheffy J, Schnall RP, Karas RH, Udelson JE. Assessment of peripheral vascular endothelial function with finger arterial pulse wave amplitude.  Am Heart J. 2003;  146 168-174
    CrossrefPubMedSuche in Google Scholar
  • 212 Ravikumar R, Deepa R, Shanthirani C, Mohan V. Comparison of carotid intima-media thickness, arterial stiffness, and brachial artery flow mediated dilatation in diabetic and nondiabetic subjects. The Chennai Urban Population Study (CUPS-9).  Am J Cardiol. 2002;  90 702-707
    CrossrefPubMedSuche in Google Scholar
  • 213 Chappey O, Dosquet C, Wautier MP, Wautier JL. Advanced glycation end products, oxidant stress and vascular lesions.  Eur J Clin Invest. 1997;  27 97-108
    CrossrefPubMedSuche in Google Scholar
  • 214 Riley WA, Freedman DS, Higgs NA, Barnes RW, Zinkgraf SA, Berenson GS. Decreased arterial elasticity associated with cardiovascular disease risk factors in the young. Bogalusa Heart Study.  Arteriosclerosis. 1986;  6 378-386
    PubMedSuche in Google Scholar
  • 215 Hopkins KD, Lehmann ED, Jones RL, Turay RC, Gosling RG. A family history of NIDDM is associated with decreased aortic distensibility in normal healthy young adult subjects.  Diabetes Care. 1996;  19 501-503
    PubMedSuche in Google Scholar
  • 216 Budoff MJ, Raggi P. Coronary artery disease progression assessed by electron-beam computed tomography.  Am J Cardiol. 2001;  88 46-50
    CrossrefPubMedSuche in Google Scholar
  • 217 Hosoi M, Sato T, Yamagami K, Hasegawa T, Yamakita T, Miyamoto M, Yoshioka K, Yamamoto T, Ishii T, Tanaka S, Itoh A, Haze K, Fujii S. Impact of diabetes on coronary stenosis and coronary artery calcification detected by electron-beam computed tomography in symptomatic patients.  Diabetes Care. 2002;  25 696-701
    PubMedSuche in Google Scholar
  • 218 Mielke CH, Shields JP, Broemeling LD. Coronary artery calcium, coronary artery disease, and diabetes.  Diabetes Res Clin Pract. 2001;  53 55-61
    CrossrefPubMedSuche in Google Scholar
  • 219 Schurgin S, Rich S, Mazzone T. Increased prevalence of significant coronary artery calcification in patients with diabetes.  Diabetes Care. 2001;  24 335-338
    PubMedSuche in Google Scholar
  • 220 Pyorala K, Laakso M, Uusitupa M. Diabetes and atherosclerosis epidemiologic view.  Diabetes Metab Rev. 1987;  3 463-524
    PubMedSuche in Google Scholar
  • 221 Dahl-Jorgensen K, Larsen JR, Hanssen KF. Atherosclerosis in childhood and adolescent type 1 diabetes: early disease, early treatment?.  Diabetologia. 2005;  48 1445-1453
    CrossrefPubMedSuche in Google Scholar

Correspondence

Francesco ChiarelliM.D., Ph.D. 

Department of Pediatrics·University of Chieti

Via dei Vestini 5

66100 Chieti

Italy

Telefon: +39/0871/35 80 15

Fax: +39/0871/57 48 31

eMail: chiarelli@unich.it